Henry J. Fuchs - Dec 1, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Dec 1, 2023
Transactions value $
$21,200
Form type
4
Date filed
12/5/2023, 04:56 PM
Previous filing
Aug 11, 2023
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21.2K +317 +0.18% $66.88 177K Apr 28, 2023 Direct F1
transaction BMRN Common Stock Award $0 +17.8K +10.06% $0.00 194K Dec 1, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Restricted stock units granted on December 1, 2023. Price not applicable.